[ad_1] Haley Burgess, SVP of provider surveillance and safety at Inovalon, discussed the operational challenges in specialty pharmacies, including high costs, complex prior authorization processes, and medication adherence issues. Burgess highlighted the role of Inovalon’s platforms, Script Med and Vigilance, in streamlining workflows, improving patient care, and enhancing pharmacist productivity by 50%. Burgess emphasized the…
[ad_1] Pharmaceutical Executive: How can AI life sciences companies stand out at the upcoming JP Morgan Healthcare Conference?Angela Schwab: There’s a few different ways. In 2025, we saw a lot of AI hype, with claims of using AI for everything and it solving all our problems. The disillusionment has set in, however, and to get…
[ad_1] Pharmaceutical Executive: How is Re-Vana using its sustained-delivery hydrogel technology to position itself as a long-term partner rather than a single-asset story at the 2026 J.P. Morgan Healthcare Conference? Michael O’Rurke: Re-Vana has two core platform technologies, and one is called EyeLief and the other is OcuLeif. What makes Re-Vana unique is that we…
[ad_1] For pharma marketers navigating internal capabilities, compliance, and control, hiring a digital agency was considered table stakes for most of pharma’s digital history. If you wanted a website, an email program, paid search, or social media, you hired an agency. But that assumption is quietly breaking. Between the maturation of internal teams, the standardization…
[ad_1] Novartis currently has two radioligand therapies approved by the FDA and is developing additional candidates. Credit: Taljat David / Shutterstock.com. Novartis has announced plans to construct a radioligand therapy (RLT) manufacturing facility in Winter Park, Florida, as part of its ongoing radioligand therapy manufacturing expansion. The facility forms a key component of the company’s…
[ad_1] Former MSD head of R&D Roger Perlmutter has continued the swift development track for cancer start-up Eikon Therapeutics, filing an IPO to build its already healthy cash position further. Eikon has raised more than $1 billion since quietly launching in 2019, most recently with its $351 million Series D last year, and is now…
[ad_1] Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast where we bring you the latest insights shaping patient access, supply chain/logistics, data & tech, and healthcare innovation. I’m your host, and let’s get into today’s headlines. Johnson & Johnson has officially joined the TrumpRx initiative, the direct-to-patient platform designed to bypass PBMs and offer “most-favored-nation”…
[ad_1] Anxiety doesn’t always look the same. Some people can point clearly to what they’re afraid of. Others feel anxious without being able to explain why. Both experiences are valid — and in Bach flower remedies, they’re supported very differently. Two remedies that are often confused are Mimulus and Aspen. They both relate to fear…
[ad_1] MediLink and Roche announce exclusive licensing agreement for YL201 …
[ad_1] January 12, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . “ data-action=”subscribe”> Subscribe We were unable to process your request. Please try…